• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠易激综合征诊断与治疗的新进展

New developments in the diagnosis and treatment of irritable bowel syndrome.

作者信息

Longstreth George F, Drossman Douglas A

机构信息

Department of Gastroenterology, Kaiser Permanente Medical Care Program, 4647 Zion Avenue, San Diego, CA 92120, USA.

出版信息

Curr Gastroenterol Rep. 2002 Oct;4(5):427-34. doi: 10.1007/s11894-002-0014-2.

DOI:10.1007/s11894-002-0014-2
PMID:12228046
Abstract

Irritable bowel syndrome (IBS) is a common disorder with major health status and economic effects. Symptom criteria are of paramount importance in diagnosis, but differences among the Manning, Rome I, and Rome II criteria may lead to variable identification of people with the disorder. Practice guidelines are based on evidence and, to a greater degree, on consensus; therefore, experts vary on the specifics of ordering particular diagnostic tests. There is an overlap of IBS symptoms with those of celiac sprue, and selected patients should be tested for the latter disease. Symptom confusion with biliary pain and overlap with chronic pelvic pain could contribute to the predisposition of IBS patients to undergo cholecystectomy and hysterectomy. Development and documentation of effective therapy has been difficult, but depending on the selection of subgroups, there is evidence for usefulness of smooth muscle relaxants, loperamide, and antidepressants. Various forms of psychological therapy and new serotonin-modulating agents seem especially promising. The placebo effect of the physician-patient relationship has important therapeutic benefit.

摘要

肠易激综合征(IBS)是一种常见疾病,对健康状况和经济有重大影响。症状标准在诊断中至关重要,但曼宁标准、罗马I标准和罗马II标准之间的差异可能导致对该疾病患者的识别存在差异。实践指南基于证据,在很大程度上基于共识;因此,专家们在订购特定诊断测试的具体细节上存在差异。IBS症状与乳糜泻症状有重叠,部分患者应接受后者的检测。与胆绞痛的症状混淆以及与慢性盆腔疼痛的重叠可能导致IBS患者倾向于接受胆囊切除术和子宫切除术。有效治疗方法的开发和记录一直很困难,但根据亚组的选择,有证据表明平滑肌松弛剂、洛哌丁胺和抗抑郁药是有用的。各种形式的心理治疗和新型5-羟色胺调节剂似乎特别有前景。医患关系的安慰剂效应具有重要的治疗益处。

相似文献

1
New developments in the diagnosis and treatment of irritable bowel syndrome.肠易激综合征诊断与治疗的新进展
Curr Gastroenterol Rep. 2002 Oct;4(5):427-34. doi: 10.1007/s11894-002-0014-2.
2
Clinical assessment of irritable bowel syndrome.肠易激综合征的临床评估
J Clin Gastroenterol. 2002 Jul;35(1 Suppl):S31-6. doi: 10.1097/00004836-200207001-00007.
3
[Celiac disease in a patient with Rome II criteria of irritable bowel syndrome].[一名符合罗马II型肠易激综合征标准的患者患有乳糜泻]
An Med Interna. 2004 Mar;21(3):154-5. doi: 10.4321/s0212-71992004000300019.
4
FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.美国食品药品监督管理局批准两种治疗肠易激综合征的药物。治疗肠易激综合征的药物种类在增加,但诊断却很棘手。
Health News. 2002 Oct;8(10):1-2.
5
Entry criteria for drug trials of irritable bowel syndrome.肠易激综合征药物试验的纳入标准。
Am J Med. 1999 Nov 8;107(5A):51S-58S. doi: 10.1016/s0002-9343(99)00079-0.
6
The challenge of irritable bowel syndrome: creating an alliance between patient and physician.肠易激综合征的挑战:建立医患联盟。
Cleve Clin J Med. 2001 Mar;68(3):224-5, 229-33, 236-7. doi: 10.3949/ccjm.68.3.224.
7
Diagnosing irritable bowel syndrome.诊断肠易激综合征。
Rev Gastroenterol Disord. 2003;3 Suppl 2:S12-7.
8
Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?依据不同诊断标准的肠易激综合征:新的罗马II标准对于研究和实践是否限制过严?
Am J Gastroenterol. 2000 Nov;95(11):3176-83. doi: 10.1111/j.1572-0241.2000.03197.x.
9
Drug treatment options for irritable bowel syndrome: managing for success.肠易激综合征的药物治疗选择:实现成功管理
Drugs Aging. 2001;18(3):201-11. doi: 10.2165/00002512-200118030-00005.
10
Drug treatment of the irritable bowel syndrome.肠易激综合征的药物治疗
Drugs. 1992 Aug;44(2):200-6. doi: 10.2165/00003495-199244020-00004.

引用本文的文献

1
Combined GWAS and single cell transcriptomics uncover the underlying genes and cell types in disorders of gut-brain interaction.全基因组关联研究(GWAS)与单细胞转录组学相结合,揭示了肠脑相互作用障碍中的潜在基因和细胞类型。
medRxiv. 2023 Jun 5:2023.06.02.23290906. doi: 10.1101/2023.06.02.23290906.
2
Prevalence and Self-recognition of Chronic Constipation: Results of an Internet Survey.慢性便秘的患病率及自我认知:一项网络调查结果
J Neurogastroenterol Motil. 2016 Oct 30;22(4):677-685. doi: 10.5056/jnm15187.
3
Organic colonic lesions in 3,332 patients with suspected irritable bowel syndrome and lacking warning signs, a retrospective case--control study.

本文引用的文献

1
Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness.肠易激综合征的催眠疗法:一项临床服务的大规模审计及影响反应性因素的检查
Am J Gastroenterol. 2002 Apr;97(4):954-61. doi: 10.1111/j.1572-0241.2002.05615.x.
2
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?肠易激综合征与其他疾病共病的系统评价:病因及影响是什么?
Gastroenterology. 2002 Apr;122(4):1140-56. doi: 10.1053/gast.2002.32392.
3
Deconstructing the placebo effect and finding the meaning response.
3332 例疑似肠易激综合征且无报警症状患者的结肠有机病变:一项回顾性病例对照研究。
Int J Colorectal Dis. 2011 Jul;26(7):935-40. doi: 10.1007/s00384-011-1163-2. Epub 2011 Mar 4.
4
Visceral pain: the neurophysiological mechanism.内脏痛:神经生理机制
Handb Exp Pharmacol. 2009(194):31-74. doi: 10.1007/978-3-540-79090-7_2.
5
Paroxetine for somatic pain associated with physical illness: a review.帕罗西汀用于治疗与躯体疾病相关的躯体疼痛:综述
Prim Care Companion J Clin Psychiatry. 2006;8(3):122-30. doi: 10.4088/pcc.v08n0301.
解构安慰剂效应并找到意义反应。
Ann Intern Med. 2002 Mar 19;136(6):471-6. doi: 10.7326/0003-4819-136-6-200203190-00011.
4
Review article: the complexity of drug development for irritable bowel syndrome.综述文章:肠易激综合征药物研发的复杂性
Aliment Pharmacol Ther. 2002 Mar;16(3):343-51. doi: 10.1046/j.1365-2036.2002.01185.x.
5
Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire.加拿大的功能性胃肠疾病:首次基于人群的使用罗马II标准的调查及问卷改进建议。
Dig Dis Sci. 2002 Jan;47(1):225-35. doi: 10.1023/a:1013208713670.
6
Antibiotics increase functional abdominal symptoms.抗生素会增加功能性腹部症状。
Am J Gastroenterol. 2002 Jan;97(1):104-8. doi: 10.1111/j.1572-0241.2002.05428.x.
7
Serotoninergic neuroenteric modulators.血清素能神经肠调节因子
Lancet. 2001 Dec 15;358(9298):2061-8. doi: 10.1016/S0140-6736(01)07103-3.
8
Irritable bowel syndrome: how far do you go in the workup?肠易激综合征:检查要做到什么程度?
Gastroenterology. 2001 Dec;121(6):1512-5. doi: 10.1053/gast.2001.29782.
9
Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome.肠易激综合征患者亚组中类似乳糜泻的异常情况。
Gastroenterology. 2001 Dec;121(6):1329-38. doi: 10.1053/gast.2001.29572.
10
Costs of care for irritable bowel syndrome patients in a health maintenance organization.健康维护组织中肠易激综合征患者的护理成本。
Am J Gastroenterol. 2001 Nov;96(11):3122-9. doi: 10.1111/j.1572-0241.2001.05258.x.